Domain interactions in the gelatinase A•TIMP-2•MT1-MMP activation complex -: The ectodomain of the 44-kDa form of membrane type-I matrix metalloproteinase does not modulate gelatinase A activation

被引:84
作者
Overall, CM
Tam, E
McQuibban, GA
Morrison, C
Wallon, UM
Bigg, HF
King, AE
Roberts, CR
机构
[1] Univ British Columbia, Dept Oral Biol & Med Sci, Vancouver, BC V6T 1Z3, Canada
[2] Univ British Columbia, Dept Biochem & Mol Biol, Vancouver, BC V6T 1Z3, Canada
关键词
D O I
10.1074/jbc.M005932200
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
On the cell surface, the 59-kDa membrane type I-matrix metalloproteinase (MT1-MMP) activates the 72-kDa progelatinase A (MMP-2) after binding the tissue inhibitor of metalloproteinases (TIMP)-2, A 44-kDa remnant of MT1-MMP, with an N terminus at Gly(285), is also present on the cell after autolytic shedding of the catalytic domain from the hemopexin carboxyl (C) domain, but its role in gelatinase A activation is unknown. We investigated intermolecular interactions in the gelatinase A activation complex using recombinant proteins, domains, and peptides, yeast two-hybrid analysis, solid- and solution-phase assays, cell culture, and immunocytochemistry, A strong interaction between the TIMP-2 C domain (Glu(153)-Pro(221)) and the gelatinase A hemopexin C domain (Gly(446)-Cys(660)) was demonstrated by the yeast two-hybrid system, Epitope masking studies showed that the anionic TIMP-2 C tail lost immunoreactivity after binding, indicating that the tail was buried in the complex. Using recombinant MT1-MMP hemopexin C domain (Gly(285)-Cys(508)), no direct role for the 44-kDa form of MT1-MMP in cell surface activation of progelatinase A was found, Exogenous hemopexin C domain of gelatinase A, but not that of MT1-MMP, blocked the cleavage of the 68-kDa gelatinase A activation intermediate to the fully active 66-kDa enzyme by concanavalin A-stimulated cells. The MT1-MMP hemopexin C domain did not form homodimers nor did it bind the gelatinase A hemopexin C domain, the C tail of TIMP-2, or full-length TIMP-2, Hence, the ectodomain of the remnant 44-kDa form of MT1-MMP appears to play little if any role in the activation of gelatinase A favoring the hypothesis that it accumulates on the cell surface as an inactive, stable degradation product.
引用
收藏
页码:39497 / 39506
页数:10
相关论文
共 54 条
[1]   Intermolecular autolytic cleavage can contribute to the activation of progelatinase A by cell membranes [J].
Atkinson, SJ ;
Crabbe, T ;
Cowell, S ;
Ward, RV ;
Butler, MJ ;
Sato, H ;
Seiki, M ;
Reynolds, JJ ;
Murphy, G .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1995, 270 (51) :30479-30485
[2]  
AZZAM HS, 1992, CANCER RES, V52, P4540
[3]   Focalized proteolysis: Spatial and temporal regulation of extracellular matrix degradation at the cell surface [J].
Basbaum, CB ;
Werb, Z .
CURRENT OPINION IN CELL BIOLOGY, 1996, 8 (05) :731-738
[4]   Specific, high affinity binding of tissue inhibitor of metalloproteinases-4 (TIMP4) to the COOH-terminal hemopexin-like domain of human gelatinase A - TIMP-4 binds progelatinase A and the COOH-terminal domain in a similar manner to TIMP-2 [J].
Bigg, HF ;
Shi, YE ;
Liu, YLE ;
Steffensen, B ;
Overall, CM .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1997, 272 (24) :15496-15500
[5]   Localization of matrix metalloproteinase MMP-2 to the surface of invasive cells by interaction with integrin alpha v beta 3 [J].
Brooks, PC ;
Stromblad, S ;
Sanders, LC ;
vonSchalscha, TL ;
Aimes, RT ;
StetlerStevenson, WG ;
Quigley, JP ;
Cheresh, DA .
CELL, 1996, 85 (05) :683-693
[6]   The TIMP2 membrane type 1 metalloproteinase "receptor" regulates the concentration and efficient activation of progelatinase A - A kinetic study [J].
Butler, GS ;
Butler, MJ ;
Atkinson, SJ ;
Will, H ;
Tamura, T ;
van Westrum, SS ;
Crabbe, T ;
Clements, J ;
d'Ortho, MP ;
Murphy, G .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1998, 273 (02) :871-880
[7]   HUMAN PROGELATINASE-A CAN BE ACTIVATED BY AUTOLYSIS AT A RATE THAT IS CONCENTRATION-DEPENDENT AND ENHANCED BY HEPARIN BOUND TO THE C-TERMINAL DOMAIN [J].
CRABBE, T ;
IOANNOU, C ;
DOCHERTY, AJP .
EUROPEAN JOURNAL OF BIOCHEMISTRY, 1993, 218 (02) :431-438
[8]  
Ellerbroek SM, 1999, BIOESSAYS, V21, P940, DOI 10.1002/(SICI)1521-1878(199911)21:11<940::AID-BIES6>3.3.CO
[9]  
2-A
[10]  
Ellerbroek SM, 1999, CANCER RES, V59, P1635